TMDX TransMedics
- 127.220
- -0.060-0.05%
- 127.220
- 0.0000.00%
TransMedics News
TransMedics(TMDX.US) Director Sells US$1.5 Million in Common Stock
$TransMedics(TMDX.US)$ Director TOBIN JAMES R sold 12,025 shares of common stock on May 3, 2024 at an average price of $125.05 for a total value of $1.5 million.Source: Announcement What is statement
Form 144 | TransMedics(TMDX.US) Director Proposes to Sell 930.3K in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $TransMedics(TMDX.US)$ Director EDWARD BASILE intends to sell 7,157 shares of its common stock on May 7, with a total market value of approximately $930.3K. Source: A
Form 144 | TransMedics(TMDX.US) Officer Proposes to Sell 418.56K in Common Stocks
SEC FILLINGS DISCLOSED/ May 6, $TransMedics(TMDX.US)$ Officer Corcoran Nicholas intends to sell 3,222 shares of its common stock on May 6, with a total market value of approximately $418.56K. Sourc
Form 144 | TransMedics(TMDX.US) Officer Proposes to Sell 1.92 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 6, $TransMedics(TMDX.US)$ Officer Gordon Stephen intends to sell 15,000 shares of its common stock on May 6, with a total market value of approximately $1.92 million. Gor
TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call Transcript
TransMedics(TMDX.US) Officer Sells US$7.99 Million in Common Stock
$TransMedics(TMDX.US)$ Officer Hassanein Waleed H sold 68,444 shares of common stock on May 1, 2, 2024 at an average price of $116.68 for a total value of $7.99 million.Source: Announcement What is st
TransMedics(TMDX.US) Director Sells US$1.6 Million in Common Stock
$TransMedics(TMDX.US)$ Director TOBIN JAMES R sold 15,040 shares of common stock on May 1, 2024 at an average price of $106.43 for a total value of $1.6 million.Source: Announcement What is statement
TransMedics(TMDX.US) Officer Sells US$8.57 Million in Common Stock
$TransMedics(TMDX.US)$ Officer Khayal Tamer I sold 78,036 shares of common stock on May 1, 2024 at an average price of $109.78 for a total value of $8.57 million.Source: Announcement What is statement
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
TransMedics Group, Inc. (TMDX) Soars to 52-Week High, Time to Cash Out?
Form 144 | TransMedics(TMDX.US) Officer Proposes to Sell 1.51 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 2, $TransMedics(TMDX.US)$ Officer Hassanein Waleed H intends to sell 12,444 shares of its common stock on May 2, with a total market value of approximately $1.51 million.
Form 144 | TransMedics(TMDX.US) Officer Proposes to Sell 1.7 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $TransMedics(TMDX.US)$ Officer Tamer Khayal intends to sell 14,776 shares of its common stock on May 1, with a total market value of approximately $1.7 million. Tamer
Why TransMedics Stock Is Soaring Today
Form 144 | TransMedics(TMDX.US) Director Proposes to Sell 3.27 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $TransMedics(TMDX.US)$ Director James R. Tobin intends to sell 27,065 shares of its common stock on May 1, with a total market value of approximately $3.27 million. Ja
TransMedics Group Is Maintained at Buy by Canaccord Genuity
TransMedics Group Is Maintained at Buy by Canaccord Genuity
Canadian Investment Banking Group: Maintaining the TransMedics Gr (TMDX.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $102.00 to $117.00.
Canadian Investment Banking Group: Maintaining the TransMedics Gr (TMDX.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $102.00 to $117.00.
Canaccord Genuity Maintains Buy on TransMedics Gr, Raises Price Target to $117
Canaccord Genuity analyst Jason Mills maintains TransMedics Gr (NASDAQ:TMDX) with a Buy and raises the price target from $102 to $117.
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to keep the federal funds rate unchanged at 5.25% to 5.5%,
TransMedics Stock Skyrockets, Analysts Call It 'One Of The Best Organic Growth Stories'
Tuesday, organ transplant-medical device firm TransMedics Group Inc (NASDAQ:TMDX) reported first-quarter EPS of 35 cents, a turnaround from an EPS loss of 8 cents a year ago, beating the consensus of
Analysis
Price Target
No Data
